Home Newsfeeds IonQ Will Be Issued U.S. Patent Number 11,580,283 Tomorrow Titled “Automated Optimization Of Large-scale Quantum Circuits With Continuous Parameters”

News

IonQ Will Be Issued U.S. Patent Number 11,580,283 Tomorrow Titled “Automated Optimization Of Large-scale Quantum Circuits With Continuous Parameters”

https://patentcenter.uspto.gov/#!/applications/16348668/ifw/docs

byHappy Mohamed

February 13, 2023

1 minute read

https://patentcenter.uspto.gov/#!/applications/16348668/ifw/docs

RBC Capital Maintains Outperform on Prometheus Biosciences, Raises Price Target to $66

By Benzinga Newsdesk

October 4, 7:17 AM

RBC Capital analyst Gregory Renza maintains Prometheus Biosciences (NASDAQ:RXDX) with a Outperform and raises the price target from $61 to $66.

RXDX

BTIG Initiates Coverage On Annexon with Buy Rating, Announces Price Target of $15

By Benzinga Newsdesk

September 9, 9:37 AM

BTIG analyst Thomas Shrader initiates coverage on Annexon (NASDAQ:ANNX) with a Buy rating and announces Price Target of $15.

ANNX

Insiders Buying Phathom Pharmaceuticals And 2 Other Stocks

By Lisa Levin

April 12, 7:57 AM

Although US stocks closed mixed on Tuesday, there were a few notable insider trades.

NYC

Raymond James Maintains Strong Buy on Construction Partners, Raises Price Target to $35

By Benzinga Newsdesk

August 19, 8:24 AM

Raymond James analyst Patrick Tyler Brown maintains Construction Partners (NASDAQ:ROAD) with a Strong Buy and raises the price target from $25 to $35.

ROAD

IonQ Will Be Issued U.S. Patent Number 11,580,283 Tomorrow Titled “Automated Optimization Of Large-scale Quantum Circuits With Continuous Parameters”

Related Posts

RBC Capital Maintains Outperform on Prometheus Biosciences, Raises Price Target to $66

BTIG Initiates Coverage On Annexon with Buy Rating, Announces Price Target of $15

Insiders Buying Phathom Pharmaceuticals And 2 Other Stocks

Raymond James Maintains Strong Buy on Construction Partners, Raises Price Target to $35